The NIH has just announced that the Electronic Medical Records and Genomics (eMERGE) consortium of seven US medical research institutions has received an additional $25M in funding for Phase II of a series of projects to study how genetic information in patients' medical records can be used to improve their care. As genome sequencing becomes increasingly affordable and more widely done, translational research is needed to show physicians how they might respond to indicators of genetic predisposition to disease in their treatment programs. The eMERGE network was formed in 2007 "to develop, disseminate, and apply approaches to research that combine DNA biorepositories with electronic medical record (EMR) systems for large-scale, high-throughput genetic research," according to the National Human Genome Research Institute (NHGRI) branch of the NIH.
Tags: Mount Sinai School of Medicine, Northeast, Vanderbilt University, University of Washington, WA, Northwest, Translational Research, New York, MSSM, BioResearch Product Faire Event, Genomics, NY, NIH, Seattle, Biomedical Research Funding, Nashville TN, 2011
This story not only amazed us but brought home how important the work of researchers and medical equipment technology developers is in real time, right now, for saving the lives of actual people. Read the update below, too. -- 12/23/2011
Tags: Harvard University, Northeast, Stem cell research, Translational Research, 2012, Massachusetts, Boston, BioResearch Product Faire Event, Event, MA, Harvard, Laboratory Equipment Supplier, Research equipment, transplant success story, 2011
Recognizing a strong opportunity for productive public-private partnership in bioscience research to benefit public health, NIH has awarded a 5-year, $5.2M grant to Boulder, Colorado-based diagnostics firm MBio to produce a reasonably-priced, no-lab-required assay system for accurate identification of the influenza virus. Their winning project proposal includes this description:
UCSD Health Sciences just announced that it will partner with Pfizer to speed delivery of new treatments to market. Pfizer has been successful with its Centers for Therapeutic Innovation (CTI) program at other major research universities, in part because of a non-traditional collaborative approach that includes constant transparency, meaning that they will share resources and information at all stages of research. What each side brings to the table:
When the President launched the Advanced Manufacturing Partnership (AMP) last month, a key component was the National Robotics Initiative (NRI), which will pool the resources of multiple government agencies to support the development of robots designed to augment the work and health of human beings. These are known as assistive systems, in contrast to the totalitarian robots of science fiction dystopias that threaten to supplant humans.
Tags: Midwest, University of Minnesota, Translational Research, Midwest life science marketing events, 2011 Research Funding, BioResearch Product Faire Event, MN, Robotics, NSF, UMinn, Twin Cities, 2011
Five years ago the federal government decided that private biomedical research companies were not bringing enough new technology to patients in need, and that it would step up that process by having the NIH fund research at academic medical institutions to bridge the gap between basic science and practical treatment. Thus the CTSA was born: the Clinical & Translational Science Awards program, a research consortium supporting the translation of science into medicine by accelerating laboratory discoveries.
Since the approval of the President's Universal Heathcare Measure, researchers at the Agency for Healthcare Research and Quality (US Dept. of Health) have been tasked not only with the challenge of clarifying the options of the proposed socialized medicine program, but with marketing health itself. If healthcare is going to be funded from the public coffer, it follows that the public has a certain responsibility not to abuse that privilege with unhealthy behaviors. Put another way, good health is the right thing to do. But how do you convince people of that? A business and healthcare administration professor at the University of Utah Eccles School of Business, Debra Scammon, concludes in a recent paper in the Journal of Public Policy & Marketing titled "Transforming Consumer Health" that the answer is a strong social marketing campaign.
In a speech given at Carnegie Mellon University in Pittsburgh on June 24, President Obama announced the launch of the $500M Advanced Manufacturing Partnership (AMP) between university research science, government agencies, and industry to increase investment in technologies that create 21st Century manufacturing jobs here in the United States. In addition to Carnegie Mellon, the research institutions involved in the initiative are: the University of Michigan, the University of California-Berkeley, MIT, Stanford, and the Georgia Institute of Technology.
Wallace Coulter was not only a fantastically successful inventor of diagnostics equipment, but through the philanthropic Coulter Foundation he continues to promote medical innovation at over 10 universities across the US. Duke University has just received a $10 million commitment to permanently endow its Coulter Translational Partnership in biomedical engineering, which, combined with grants from the Fitzpatrick Foundation and other Duke resources brings the program's endowed resources to $20 million, securing its long term future.
Construction crews on Civic Center Blvd. at the University of Pennsylvania have been very busy the past few years, and now Penn Med has an impressive research facility that is filling fast.